Dr. Grosh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5910 Mechunk Ridge lane
Keswick, VA 22947Phone+1 434-296-5593Fax+1 434-296-4399- Is this information wrong?
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1980 - 1982
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1974 - 1977
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1974
Certifications & Licensure
- VA State Medical License 1988 - 2024
- TN State Medical License 1980 - 1988
- WI State Medical License 1977 - 1979
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery Start of enrollment: 2005 Jul 01
- Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer Start of enrollment: 2018 Oct 29
Publications & Presentations
PubMed
- 6 citationsPhase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64).Rick Daniel Vavolizza, Gina R Petroni, Ileana S Mauldin, Kimberly A Chianese-Bullock, Walter C Olson, Kelly T Smith, Lynn T Dengel, Kathleen Haden, William W Grosh, Va...> ;Journal for Immunotherapy of Cancer. 2022 Sep 1
- 9 citationsImmunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.Max O. Meneveau, Gina R. Petroni, Elise P. Salerno, Kevin T. Lynch, Mark E. Smolkin, Elizabeth M. H. Woodson, Kimberly A. Chianese-Bullock, Walter C. Olson, Donna H. D...> ;Journal for Immunotherapy of Cancer. 2021 May 1
- 15 citationsTrial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).Craig L. Slingluff, Gina R. Petroni, Kimberly A. Chianese-Bullock, Nolan A. Wages, Walter C. Olson, Kelly T. Smith, Kathleen Haden, Lynn T. Dengel, Anna Dickinson, Car...> ;Journal for Immunotherapy of Cancer. 2021 Jan 1
- Join now to see all
Grant Support
- Evalof Immune Status Following The Administration Of Chemotherapy Or SteroidsNational Center For Research Resources2009
- Evalof Immune Status Following The Administration Of Chemotherapy Or SteriodsNational Center For Research Resources2008
- Taxol In Refractory Ovarian CancerNational Center For Research Resources1993
Professional Memberships
- Member
Hospital Affiliations
- University of Virginia Medical CenterCharlottesville, Virginia
- Emily Couric Clinical Cancer CenterCharlottesville, Virginia
- Salem Veterans Affairs Medical CenterSalem, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: